NASDAQ:OFIX - Orthofix Medical Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Orthofix Medical Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $28.47 +0.17 (+0.60 %) (As of 03/31/2020 03:02 PM ET) Add Compare Today's Range$28.15Now: $28.47▼$29.4250-Day Range$22.73MA: $34.26▼$46.0252-Week Range$22.11Now: $28.47▼$57.85Volume8,009 shsAverage Volume221,530 shsMarket Capitalization$546.05 millionP/E RatioN/ADividend YieldN/ABeta0.62 ProfileAnalyst RatingsAdvanced ChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures. The Spinal Implants segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Orthofix Extremities segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.Read More Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment SectorMedical Current SymbolNASDAQ:OFIX Previous Symbol CUSIPN6748L10 CIK884624 Webhttp://www.orthofix.com/ Phone214-937-2000Debt Debt-to-Equity Ratio0.06 Current Ratio3.07 Quick Ratio2.10Price-To-Earnings Trailing P/E RatioN/A Forward P/E Ratio27.64 P/E GrowthN/A Sales & Book Value Annual Sales$459.95 million Price / Sales1.19 Cash Flow$3.28 per share Price / Cash Flow8.67 Book Value$17.22 per share Price / Book1.65Profitability EPS (Most Recent Fiscal Year)$1.47 Net Income$-28,460,000.00 Net Margins-6.19% Return on Equity8.58% Return on Assets5.86%Miscellaneous Employees1,055 Outstanding Shares19,180,000Market Cap$546.05 million Next Earnings Date5/4/2020 (Estimated) OptionableOptionable Receive OFIX News and Ratings via Email Sign-up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter. NASDAQ:OFIX Rates by TradingView Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions How has Orthofix Medical's stock been impacted by COVID-19 (Coronavirus)? Orthofix Medical's stock was trading at $30.67 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, OFIX stock has decreased by 7.3% and is now trading at $28.42. View which stocks have been mosted impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Orthofix Medical? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Orthofix Medical. When is Orthofix Medical's next earnings date? Orthofix Medical is scheduled to release its next quarterly earnings announcement on Monday, May 4th 2020. View our earnings forecast for Orthofix Medical. How were Orthofix Medical's earnings last quarter? Orthofix Medical Inc (NASDAQ:OFIX) announced its quarterly earnings results on Monday, February, 24th. The medical device company reported $0.51 EPS for the quarter, hitting the Zacks' consensus estimate of $0.51. The medical device company had revenue of $121.49 million for the quarter, compared to analysts' expectations of $122.90 million. Orthofix Medical had a positive return on equity of 8.58% and a negative net margin of 6.19%. View Orthofix Medical's earnings history. What guidance has Orthofix Medical issued on next quarter's earnings? Orthofix Medical updated its first quarter 2020 After-Hours earnings guidance on Monday, February, 24th. The company provided earnings per share (EPS) guidance of 0.09-0.12 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.32. The company issued revenue guidance of $106-109 million, compared to the consensus revenue estimate of $113.27 million. What price target have analysts set for OFIX? 2 analysts have issued 12 month price targets for Orthofix Medical's stock. Their forecasts range from $42.00 to $56.00. On average, they anticipate Orthofix Medical's stock price to reach $49.00 in the next twelve months. This suggests a possible upside of 72.4% from the stock's current price. View analysts' price targets for Orthofix Medical. Has Orthofix Medical been receiving favorable news coverage? News headlines about OFIX stock have trended very negative recently, InfoTrie Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Orthofix Medical earned a media sentiment score of -3.0 on InfoTrie's scale. They also assigned news articles about the medical device company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next few days. View the latest news aboutOrthofix Medical. Are investors shorting Orthofix Medical? Orthofix Medical saw a decrease in short interest in March. As of March 13th, there was short interest totaling 224,700 shares, a decrease of 40.4% from the February 27th total of 377,300 shares. Based on an average daily volume of 174,700 shares, the days-to-cover ratio is presently 1.3 days. Currently, 1.2% of the shares of the company are short sold. View Orthofix Medical's Current Options Chain. Who are some of Orthofix Medical's key competitors? Some companies that are related to Orthofix Medical include Abbott Laboratories (ABT), Medtronic (MDT), Stryker (SYK), Becton Dickinson and (BDX), Intuitive Surgical (ISRG), Boston Scientific (BSX), Baxter International (BAX), Edwards Lifesciences (EW), DexCom (DXCM), IDEXX Laboratories (IDXX), ResMed (RMD), Teleflex (TFX), Insulet (PODD), Steris (STE) and Masimo (MASI). What other stocks do shareholders of Orthofix Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Exxon Mobil (XOM), Clovis Oncology (CLVS), Esperion Therapeutics (ESPR), Gilead Sciences (GILD), Intercept Pharmaceuticals (ICPT), Madrigal Pharmaceuticals (MDGL), Zogenix (ZGNX) and Allergan (AGN). Who are Orthofix Medical's key executives? Orthofix Medical's management team includes the following people: Mr. Bradley R. Mason, Pres, CEO & Director (Age 65)Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 53)Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 54)Mr. Michael M. Finegan, Chief Strategy Officer (Age 55)Mr. Davide Bianchi, Pres of Global Extremities (Age 54) What is Orthofix Medical's stock symbol? Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX." How do I buy shares of Orthofix Medical? Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Orthofix Medical's stock price today? One share of OFIX stock can currently be purchased for approximately $28.42. How big of a company is Orthofix Medical? Orthofix Medical has a market capitalization of $545.10 million and generates $459.95 million in revenue each year. The medical device company earns $-28,460,000.00 in net income (profit) each year or $1.47 on an earnings per share basis. Orthofix Medical employs 1,055 workers across the globe. View additional information about Orthofix Medical. What is Orthofix Medical's official website? The official website for Orthofix Medical is http://www.orthofix.com/. How can I contact Orthofix Medical? Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected] MarketBeat Community Rating for Orthofix Medical (NASDAQ OFIX)Community Ranking: 2.3 out of 5 ( )Outperform Votes: 371 (Vote Outperform)Underperform Votes: 438 (Vote Underperform)Total Votes: 809MarketBeat's community ratings are surveys of what our community members think about Orthofix Medical and other stocks. Vote "Outperform" if you believe OFIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OFIX will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 3/31/2020 by MarketBeat.com StaffFeatured Article: What are Institutional Investors?
